Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

30 March 2018

Statement in response to the EU Council ratifying the Brexit transition deal

23 March 2018

Today’s agreement on a transition period is welcome news for […]

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Supply chain commitment to tackling problem of medicine shortages

2 March 2018

El sistema español podría mejorar su coste-eficiencia con un plan nacional

27 February 2018

IGBA congratulates the Australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance

29 January 2018

2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems

25 January 2018

This week in London, Medicines for Europe gathers regulators and […]

Vigilance saves lives! More focus needed on sustainability and patient engagement

24 January 2018

National authorities, regulators, industry leaders and key stakeholders gathered in […]

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

18 January 2018

Geneva, 18 January 2018 – Today, the AMR Industry Alliance […]